A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 [naronapride] in Patients With Chronic Idiopathic Constipation
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Naronapride (Primary)
- Indications Constipation
- Focus Pharmacogenomic; Therapeutic Use
- 07 Aug 2012 Additional trial locations (Belgium, Germany, United Kingdom) added as reported by European Clinical Trials Database record.
- 22 Aug 2008 Status changed from in progress to discontinued as reported in an ARYx media release.
- 22 Aug 2008 Primary endpoint met; results reported in an ARYx Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History